The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-methyl-4-(3-(methylamino)pyrrolidin-1-yl)benzofuro[3,2-d]pyrimidine-8-carboxamide ID: ALA1092881
PubChem CID: 46885182
Max Phase: Preclinical
Molecular Formula: C17H19N5O2
Molecular Weight: 325.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1ccc2oc3c(N4CCC(NC)C4)ncnc3c2c1
Standard InChI: InChI=1S/C17H19N5O2/c1-18-11-5-6-22(8-11)16-15-14(20-9-21-16)12-7-10(17(23)19-2)3-4-13(12)24-15/h3-4,7,9,11,18H,5-6,8H2,1-2H3,(H,19,23)
Standard InChI Key: COMUBDYHRWXOAJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
10.5090 -26.3872 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4948 -25.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4936 -26.2369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2080 -26.6495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2062 -24.9975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9211 -25.4064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9260 -26.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7175 -26.4890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7096 -25.1452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1994 -25.8133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0210 -25.7225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3538 -24.9639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8589 -24.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0390 -24.3899 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2618 -27.1706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9313 -27.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5961 -27.1640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3372 -26.3811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3815 -27.4149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9915 -26.8601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7806 -24.9979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7804 -24.1734 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0666 -25.4104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3525 -24.9983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 2 0
12 13 1 0
3 4 1 0
13 14 2 0
14 9 1 0
11 1 1 0
1 15 1 0
4 7 2 0
7 8 1 0
8 10 1 0
9 6 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 1 1 0
2 3 2 0
17 19 1 0
6 5 2 0
19 20 1 0
9 10 2 0
2 21 1 0
5 2 1 0
21 22 2 0
10 11 1 0
21 23 1 0
6 7 1 0
23 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 325.37Molecular Weight (Monoisotopic): 325.1539AlogP: 1.53#Rotatable Bonds: 3Polar Surface Area: 83.29Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.49CX LogP: 0.97CX LogD: -1.09Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.76Np Likeness Score: -1.13
References 1. Cramp S, Dyke HJ, Higgs C, Clark DE, Gill M, Savy P, Jennings N, Price S, Lockey PM, Norman D, Porres S, Wilson F, Jones A, Ramsden N, Mangano R, Leggate D, Andersson M, Hale R.. (2010) Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists., 20 (8): [PMID:20299215 ] [10.1016/j.bmcl.2010.02.097 ]